Sounds like a way to mimic the success of over the counter medications like ibuprofen, whose prices have been slowly creeping up for years.

Many of the major profitable blood pressure and statins are off patent, so the drug companies need to make more money.

I’m sure this status will limit or eliminate insurance contributions, so now you’ll pay more for generic because 50 million individuals lack the buying power of CVS and the other PBMs.